Hepatitis C Virus Testing and Care Cascade Among Transgender and Gender Diverse Individuals.

[1]  O. Panagiotou,et al.  US Black-White Differences in Mortality Risk Among Transgender and Cisgender People in Private Insurance, 2011-2019. , 2022, American journal of public health.

[2]  T. Shireman,et al.  Improving Data-Driven Methods to Identify and Categorize Transgender Individuals by Gender in Insurance Claims Data. , 2022, LGBT health.

[3]  Kendall A Lawley,et al.  Prevalence of Private and Public Health Insurance Among Transgender and Gender Diverse Adults , 2022, Medical care.

[4]  G. Moradi,et al.  The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis , 2021, European Journal of Medical Research.

[5]  Hill L. Wolfe,et al.  Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults. , 2021, Drug and alcohol dependence.

[6]  W. Mcfarland,et al.  High hepatitis C virus seropositivity, viremia, and associated risk factors among trans women living in San Francisco, California , 2021, PloS one.

[7]  J. Hecht,et al.  Hepatitis C care cascades for three populations at high risk: low-income trans women, young people who inject drugs, and men who have sex with men and inject drugs. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Mardge H. Cohen,et al.  Direct-acting antiviral Hepatitis C treatment cascade and barriers to treatment initiation among US men and women with and without HIV. , 2020, The Journal of infectious diseases.

[9]  Madeline B. Deutsch,et al.  Beyond Gender Identity Disorder Diagnoses Codes , 2020, Medical care.

[10]  Dustin M. Long,et al.  Prevalence of Sexually Transmitted Infections and Human Immunodeficiency Virus in Transgender Persons: A Systematic Review , 2020, Transgender health.

[11]  N. Terrault,et al.  Hepatitis C Screening Rates and Care Cascade in a Large US Insured Population, 2010-2016: Gaps to Elimination. , 2020, Population health management.

[12]  Stephen R. Spriggs,et al.  CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  B. Edlin,et al.  HIV and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017. , 2020, The Journal of infectious diseases.

[14]  W. Mcfarland,et al.  Hepatitis C seroprevalence and engagement in related care and treatment among trans women , 2019, Journal of viral hepatitis.

[15]  W. Thompson,et al.  Trend analysis in hepatitis C testing, OptumLabs® Data Warehouse, 2011–2017 , 2019, Online Journal of Public Health Informatics.

[16]  Jonathan Mermin,et al.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016 , 2018, Hepatology.

[17]  T. Sipe,et al.  Estimating the Prevalence of HIV and Sexual Behaviors Among the US Transgender Population: A Systematic Review and Meta-Analysis, 2006-2017. , 2019, American journal of public health.

[18]  R. Bolan,et al.  Using Sexual Orientation and Gender Identity to Monitor Disparities in HIV, Sexually Transmitted Infections, and Viral Hepatitis , 2018, American journal of public health.

[19]  C. Beyrer,et al.  Epidemiology of HIV, Sexually Transmitted Infections, Viral Hepatitis, and Tuberculosis Among Incarcerated Transgender People: A Case of Limited Data , 2018, Epidemiologic reviews.

[20]  S. Hariri,et al.  Monitoring the hepatitis C care cascade using administrative claims data. , 2018, The American journal of managed care.

[21]  Z. Butt,et al.  Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets. , 2018, The International journal on drug policy.

[22]  M. Markatou,et al.  Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians , 2018, World journal of hepatology.

[23]  A. Agardh,et al.  Self-Reported Discrimination in Health-Care Settings Based on Recognizability as Transgender: A Cross-Sectional Study Among Transgender U.S. Citizens , 2017, Archives of sexual behavior.

[24]  I. Weisberg,et al.  Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy , 2017, European journal of gastroenterology & hepatology.

[25]  A. Scheim,et al.  HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action , 2017, Current HIV/AIDS Reports.

[26]  T. Finlayson,et al.  Health Care Use and HIV-Related Behaviors of Black and Latina Transgender Women in 3 US Metropolitan Areas: Results From the Transgender HIV Behavioral Survey , 2017, Journal of acquired immune deficiency syndromes.

[27]  R. Zimmerman,et al.  Non-medical use of prescription drugs and HIV risk behaviour in transgender women in the Mid-Atlantic region of the United States , 2016, International journal of STD & AIDS.

[28]  F. Barbone,et al.  Prevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Transgender Persons Referred to an Italian Center for Total Sex Reassignment Surgery , 2016, Sexually transmitted diseases.

[29]  S. Reisner,et al.  Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. , 2015, Social science & medicine.

[30]  S. Reisner,et al.  Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center , 2015, AIDS care.

[31]  A. Ara,et al.  New Direct-Acting Antiviral Therapies for Treatment of Chronic Hepatitis C Virus Infection. , 2015, Gastroenterology & hepatology.

[32]  A. Katz,et al.  Prevalence of HCV infection among clients in community-based health settings in Hawaii, 2002-2010: assessing risk factors. , 2014, American journal of public health.

[33]  J. Quarleri,et al.  HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina , 2014, Journal of medical virology.

[34]  J. Ward,et al.  Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians , 2013, MMWR. Morbidity and mortality weekly report.

[35]  Rebecca L Morgan,et al.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[36]  L. Dixon,et al.  Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness. , 2010, Psychiatric services.

[37]  A. Rosenblum,et al.  Lifetime Risk Factors for HIV/Sexually Transmitted Infections Among Male-to-Female Transgender Persons , 2009, Journal of acquired immune deficiency syndromes.